Cargando…
Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension
Nifedipine is a dihydropyridine calcium-channel blocker (CCB) introduced approximately 30 years ago for the prophylaxis of angina symptoms, and then later utilized as an anti-hypertensive agent. In the 1990s, several meta-analyses and a case-control study were published which raised concern regardin...
Autores principales: | Lundy, Amber, Lutfi, Nahla, Beckey, Cherylyn |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686260/ https://www.ncbi.nlm.nih.gov/pubmed/19475779 |
Ejemplares similares
-
High-risk patients benefit most from nifedipine GITS–telmisartan combination
por: Aalbers, J
Publicado: (2010) -
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS)
por: Meredith, Peter A, et al.
Publicado: (2013) -
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the ‘ACTION' database in patients with angina
por: Elliott, H L, et al.
Publicado: (2011) -
Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL)
por: Lv, Rong, et al.
Publicado: (2021) -
Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
por: Toal, Corey B., et al.
Publicado: (2012)